Recommended
Membrane Protein Drug Discovery In Vitro Assays Membrane Protein In Vitro Assay Kits Membrane Protein Stable Cell Lines Membranes Membrane Protein Virus Particles Membrane Staining and Imaging Reagents
  1. Home
  2. SLAMF7
  3. mProX™ Human SLAMF7 Stable Cell Line
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
    • 1- Membrane Protein Stable Cell Line-DiscoverMP Membrane Protein Stable Cell Line, Drug Discovery Tools
    1- Membrane Protein Stable Cell Line-DiscoverMP Other Cell Lines,Drug Discovery Tools

    mProX™ Human SLAMF7 Stable Cell Line

    [CAT#: S01YF-1023-PY289]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Bulk Quote

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Other Targets
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;RAW264.7
    Target Classification
    Other Targets Drug Discovery Assays and Products
    Target Research Area
    Cancer Research
    Related Diseases
    Plasmablastic Lymphoma; Smoldering Myeloma
    Gene ID
    Human:57823
    UniProt ID
    Human:Q9NQ25

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    SLAMF7, also known as CS1, is a protein that has been studied in various medical contexts. In IgG4-related disease (IgG4-RD), SLAMF7 is being evaluated as a potential target for treatment, along with other biologics and targeted agents. In plasmablastic lymphoma (PBL), SLAMF7 is being investigated as a diagnostic marker and a potential target for therapy. In silica particles-induced pulmonary inflammation, SLAMF7 is implicated in autophagy dysfunction and m6A modification. In multiple myeloma (MM), SLAMF7 is considered a promising immunotherapeutic target, and monoclonal antibodies targeting SLAMF7 have shown positive outcomes in clinical trials. Additionally, SLAMF7 has been identified as a biomarker associated with MM in liquid biopsy analysis. These studies highlight the diverse applications of SLAMF7 in different diseases and its potential as a therapeutic target.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human SLAMF7 Stable Cell Line (S01YF-1023-PY289). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Cameron Davis (Verified Customer)

    What is the significance of SLAMF7 in multiple myeloma? Jun 11 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    SLAMF7 is highly expressed on immunosuppressive T cells in multiple myeloma, suggesting that anti-SLAMF7 antibodies can boost anti-tumor immune responses in cancer patients. Jun 11 2021

    chat Alex Smith (Verified Customer)

    How does SLAMF7 expression influence macrophage activation in inflammation? Jan 31 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    SLAMF7 up-regulation on macrophages drives superactivation in inflammatory human diseases, indicating its role in both acute and chronic inflammatory conditions. Jan 31 2022

    Related Products by Target
    • mProX™ Human SLAMF7 Stable Cell Line (CAT#: S01YF-1023-PY289)
    • Magic™ Human SLAMF7 HEK293T Cell Line (CAT#: S01YF-0123-KX218)
    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare